Cdc7-IN-19

• Description:

  Cdc7-IN-19 (compound 1-1) is a potent CDC7 inhibitor with an IC50 of 1.49 nM[1].

• UNSPSC:

  12352005

• Target:

  CDK

• Type:

  Reference compound

• Related Pathways:

  Cell Cycle/DNA Damage

• Applications:

  Cancer-Kinase/protease

• Field of Research:

  Cancer

• Assay Protocol:

  https://www.medchemexpress.com/cdc7-in-19.html

• Solubility:

  10 mM in DMSO

• Smiles:

  O=C1C2=C(NC([C@]3([H])N4CCC(CC4)C3)=N1)C5=C(C6=CNN=C6CCC5)O2

• Molecular Formula:

  C19H21N5O2

• Molecular Weight:

  351.40

• References & Citations:

  [1]LU Lun, et al. Tetracyclic compound used as cdc7 inhibitor. WO2021032170A1.

• Shipping Conditions:

  Room temperature

• Scientific Category:

  Reference compound1

• Clinical Information:

  No Development Reported

• Isoform:

  CDC

• CAS Number:

  [2606780-39-4]